Eye tech com­pa­ny snags first-ever ap­proval for spray to di­late pupils for di­ag­nos­tic ex­ams

Eye tech­nol­o­gy com­pa­ny Eye­n­ovia snagged its first ever FDA ap­proval Mon­day with the green light for My­d­com­bi, which the com­pa­ny calls the first ap­proved oph­thalmic spray for my­dri­a­sis, or di­lat­ed pupils.

My­d­com­bi, a spray made up of tropi­camide and phenyle­phrine hy­drochlo­ride, is de­signed to di­late the pupil in or­der to make eye ex­ams more ef­fi­cient and to help keep pupils di­lat­ed dur­ing cataract surgery. Eye­n­ovia says it’s al­so the first fixed-dose com­bi­na­tion of tropi­camide and phenyle­phrine in the Unit­ed States.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER